North America Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 – 2028
The North America Facial Aesthetics Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028).
For facial aesthetics, a variety of products are available, including chemical peels, cosmetic implants, dermal fillers, Botulinum toxin, and microdermabrasion. The applications of facial aesthetic therapy comprise lip augmentation, facial line correction, scar treatment, wrinkle reduction, and face lifting. Scars, blemishes, and facial wrinkles can all be diminished with laser skin resurfacing. Microdermabrasion is a minimally invasive process used to enhance the overall tone and texture of the skin.
This procedure has several advantages and uses a modestly harsh device to carefully remove the thicker, uneven outer layer. Additionally, a rise in young people's self-awareness regarding physical attractiveness fuels the need for facial aesthetic treatments. Increased sedentary behavior among young people also contributed to appearance problems, like facial hair and pigmentation, making them more self-conscious and driving up demand for facial aesthetic procedures.
Governments in regional countries are continuously working on the improvement of their healthcare infrastructure. For example, according to the Canadian Institute for Health Information, the United States spends more than any other country on healthcare services. On average, it spends more per person than the other OECD nations. These expenses are paid for by a diverse range of public payers, including the state, federal, and local governments, private insurance, and individual contributions. There is not a solitary national health insurance program.
The US market dominated the North America Facial Aesthetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,004.9 million by 2028. The Canada market is poised to grow at a CAGR of 16.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 15.3% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
Scope of the Study
Market Segments covered in the Report:
By Product
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook